Quinidine therapy and therapeutic drug monitoring in four patients with KCNT1 mutations
{{output}}
Several recent studies have reported potassium sodium-activated channel subfamily T member 1 (KCNT1) mutations in epilepsy patients on quinidine therapy. The efficacy and safety of quinidine for epilepsy treatment, however, remains controversial. We herein rep... ...
